Ubaka Ogbogu

Ubaka Ogbogu is an Assistant Professor and the Katz Group Research Fellow in Health Law at the Faculty of Law, University of Alberta. His teaching and research interests include health law, law and biotechnology, law and bioethics, science and regulation, and legal history. Ubaka is a former SCN trainee and a recipient of the SCN Canadian Alumni Award. He has done extensive research work on the ethical, legal and social issues associated with stem cell research, and continues to research and publish in this area. Ubaka holds law degrees at the bachelors and masters levels from the University of Benin in Nigeria and the University of Alberta, and is currently in the process of completing a doctorate in law at the University of Toronto. His doctoral work focuses on the legal history of early health care and biotechnology policies in Canada, particularly in relation to smallpox vaccination and infectious diseases.

Posts by: Ubaka

Stem cell pseudoscience in the courts?

Author: Ubaka Ogbogu, 02/26/13

Patients contemplating medical travel for the purpose of receiving scientifically unproven stem cell treatments may wish to consider one more potential side effect: the possibility of losing their eligibility for health status-related compensation and benefits. In May 2012, a United States appeal court affirmed an earlier New York district court decision to deny disability and…Read more

Federal Government proposes amendments to Canada’s embryo research law

Author: Ubaka Ogbogu, 05/18/12

The Federal Government has proposed amendments to the Assisted Human Reproduction Act, the legislation that governs embryo research, including many aspects of stem cell research. The amendments, which are contained in an omnibus budget implementation bill tabled before Parliament on April 26, seeks primarily to implement the 2010 Supreme Court of Canada ruling that invalidated…Read more

EU stem cell patent ruling: too early to predict impact

Author: Ubaka Ogbogu, 10/20/11

The Court of Justice of the European Union (ECJ) ruled this week that scientific research patents cannot be granted for human embryonic stem cell products under European Union (EU) law. The patent in issue, held by Dr. Oliver Brüstle, Director of the Institute of Reconstructive Neurobiology at the University of Bonn, concerns isolated and purified…Read more

US Appeal Court reinstates Obama’s funding policy on stem cell research

Author: Ubaka Ogbogu, 05/02/11

A few months ago I wrote about a temporary injunction (ban) issued by United States federal district court judge Royce C. Lamberth on federal funding for research on human embryonic stem cell lines derived from supernumerary IVF embryos. Subsequently, at the request of the federal government, a U.S. appeal court suspended the injunction pending a…Read more

Integrating stem cell technologies into health care: It’s time to get our priorities straight

Author: Ubaka Ogbogu, 04/27/11

While preparing a consulting report on ethical issues associated with priority setting (a.k.a. resource allocation, rationing) in the stem cell research context, I was surprised to find that there are no published Canadian studies of priority-setting matters pertaining specifically to stem cell research or stem cell-based technologies. A search of the Canadian Institutes of Health…Read more

Aussies review embryonic and cloning legislation

Author: Ubaka Ogbogu, 03/17/11

The Australian government is currently reviewing their stem cell and cloning research laws. The review, which began on December 22, 2010 with the appointment of an independent Legislation Review Committee (LRC) chaired by a retired federal judge, is the second since the enactment in 2002 of the Prohibition of Human Cloning for Reproduction Act and…Read more

Regulatory landscape for assisted reproduction and related research in Canada

Author: Ubaka Ogbogu, 02/08/11

A few weeks ago I blogged about the recent Supreme Court of Canada decision on the constitutional validity of several sections of the Assisted Human Reproduction Act, Canada’s assisted reproduction and embryo research legislation. I am currently preparing a paper for the Health Law Review looking at the impact of the decision on activities regulated by the Act. The paper includes a table…Read more

Implications of court decision and research ethics policy update in Canada

Author: Ubaka Ogbogu, 01/13/11

A couple of significant updates to report on from the ethics and law arena: On December 22, 2010, the Supreme Court of Canada (SCC) released its long-awaited judgment in the Reference re: Assisted Human Reproduction Act case involving a constitutional challenge brought by the province of Quebec against several sections of the Assisted Human Reproduction…Read more

Obama Administration issues memorandum on principles of scientific integrity

Author: Ubaka Ogbogu, 01/04/11

In March 2009, in his remarks at the signing of an Executive Order to reverse the Bush-era stem cell research funding restrictions, President Obama directed John P. Holdren, Director of the Office of Science and Technology Policy, to “develop a strategy for restoring scientific integrity to government decision making” by ensuring that science policy is…Read more

US report sets out basic ethical principles for assessing emerging technologies

Author: Ubaka Ogbogu, 12/16/10

President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President in May following the announcement by the J. Craig Venter Institute of the creation…Read more